Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Barrett's esophagus and esophageal cancer is levelling off in Europe

Barrett's esophagus and esophageal adenocarcinoma in the United Kingdom and the Netherlands is levelling off, reports the latest issue of the Alimentary Pharmacology & Therapeutics.

News image

Barrett's esophagus is a risk factor for esophageal adenocarcinoma.

Several studies report increasing incidences of Barrett's esophagus with substantial variation.

Dr Masclee and colleagues from the Netherlands determined age- and sex-stratified incidence rates of Barrett's esophagus and esophageal adenocarcinoma.

The team performed a cohort study using 2 primary care databases in the United Kingdom and the Netherlands.

Barrett's esophagus and esophageal adenocarcinoma cases were identified using disease-specific READ codes, and free-text search with manual validation.

Age- and sex-specific incidence rates were calculated for both Barrett's esophagus and esophageal adenocarcinoma.
Incident rates of Barrett's was 24 times higher in males across all age groups
Alimentary Pharmacology & Therapeutics

From the study population of 6,885,420 subjects in the UK, the team identified 12,312 incident Barrett's esophagus, and 40 subsequent incident esophageal adenocarcinoma cases.

There were 1383 incident Barrett's esophagus, and subsequent 5 incident esophageal adenocarcinoma cases among the 1,487,191 subjects in the Netherlands.

The team found that the incident rate of Barrett's esophagus increased linearly with age, and was 16 per 100,000 PYs in the United Kingdom, and 24 per 100,000 PYs in the Netherlands for patients aged 4044 years, increasing to 86 per 100,000 PYs in the United Kingdom, and 87 per 100,000 PYs in the Netherlands for 7074 years.

In both the United Kingdom and the Netherlands, incident rates of Barrett's esophagus was 24 times higher in males than females across all age groups.

The team observed that with respect to calendar time, the incident rate of Barrett's esophagus increased by 35% in the United Kingdom, and 41% in the Netherlands from 2000 to 2003, after which incident rates remained stable until 2012.

Dr Masclee's team concludes, "The incidence rates of Barrett's esophagus in the United Kingdom and the Netherlands increased until 2003, but levelled off thereafter."

"Around 0.3% of patients with Barrett's esophagus developed esophageal adenocarcinoma at least 1 year after Barrett's esophagus diagnosis. "

"These findings may help tailor endoscopic surveillance strategies among patients with Barrett's esophagus."

Aliment Pharmacol Ther 2014: 39(11): 13211330
22 May 2014

Go to top of page Email this page Email this page to a colleague

 30 August 2015

Advanced search
 28 August 2015 
Statin use and survival in pancreatic cancer
 28 August 2015 
Bacterial endotoxin and NAFLD
 28 August 2015 
Interferon-free regimens for Hep C
 27 August 2015 
HCV in Egypt
 27 August 2015 
Gene expression for hepatocellular carcinoma
 27 August 2015 
Liver abnormalities in celiac disease
 26 August 2015 
Medical management of diverticular disease
 26 August 2015 
Treatment of erosive esophagitis
 26 August 2015 
Dermatological complications of anti-TNF therapy in IBD
 25 August 2015 
Markers for colorectal cancer screening
 25 August 2015 
Long-term PPI use and serum gastrin levels
 25 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Cirrhosis in Hepatitis C patients
 24 August 2015 
Aspirin use and colorectal cancer survival
 21 August 2015 
Activity indexes in ulcerative colitis
 21 August 2015 
Coffee and gallstone disease
 21 August 2015 
Alcoholic cirrhosis in relapse after liver transplant
 20 August 2015 
Cirrhosis in the USA
 20 August 2015 
Mortality causes in liver cirrhosis
 20 August 2015 
Risk of death in IBD
 19 August 2015 
Predicting intestinal surgery in Crohn's disease
 19 August 2015 
Improved screening colonoscopy quality
 19 August 2015 
Sleep positioning device reduces reflux
 18 August 2015 
Health insurance influences HCV screening outcomes
 18 August 2015 
Somatostatin analogues in polycystic liver disease
 18 August 2015 
Global consensus report on H. pylori gastritis
 17 August 2015 
Biomarker of fibrosis stage in NAFLD
 17 August 2015 
Prognostic score for primary biliary cirrhosis
 17 August 2015 
Measuring subjective health in patients with IBS
 14 August 2015 
Factors that influence ulcerative colitis procedure type
 14 August 2015 
H. pylori in African American and Hispanic veterans
 14 August 2015 
Hep E virus in decompensated chronic liver disease
 13 August 2015 
H. pylori in drinking water
 13 August 2015 
Sofosbuvir-regimens in HCV
 13 August 2015 
IBS among Japanese adolescents
 12 August 2015 
Infliximab in patients in IBD
 12 August 2015 
Peritoneal carcinomatosis in colorectal cancer
 12 August 2015 
Predictors of severity of IBD
 11 August 2015 
H. pylori and immune thrombocytopenic purpura
 11 August 2015 
Chemotherapy and intestinal microbiomes
 11 August 2015 
Sexual dysfunction after rectal cancer treatment
 10 August 2015 
Scoring systems to predict alcoholic hepatitis outcomes
 10 August 2015 
Sofosbuvir-based regimens in veterans with HCV
 10 August 2015 
Predicting lymph node metastasis in T1 colorectal cancer
 07 August 2015 
Factors associated with changes in ulcerative colitis
 07 August 2015 
Bariatric surgery and NASH in obese patients
 07 August 2015 
Caffeine and fibrosis in Hep C
 06 August 2015 
Disparities in colonoscopic examination
 06 August 2015 
Weight loss and NASH
 06 August 2015 
Diagnosis of IBS
 05 August 2015 
Gender differences in fecal immunochemical tests
 05 August 2015 
Adenoma detection rates with a screening colonoscopy program
 05 August 2015 
Extraintestinal manifestations in IBD diagnosis
 04 August 2015 
IBD environmental risk factors
 04 August 2015 
Measuring disease activity in Crohn's
 04 August 2015 
Gastric emptying and hyperglycemia in diabetes
 03 August 2015 
Vaccinations and IBD
 03 August 2015 
Lack of response to therapy in severe ulcerative colitis
 03 August 2015 
Nutritional vs biological therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us